Compare BRBR & MMS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | BRBR | MMS |
|---|---|---|
| Founded | 2019 | 1975 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Packaged Foods | Business Services |
| Sector | Consumer Staples | Consumer Discretionary |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 4.0B | 4.7B |
| IPO Year | 2019 | 1997 |
| Metric | BRBR | MMS |
|---|---|---|
| Price | $17.79 | $74.32 |
| Analyst Decision | Buy | |
| Analyst Count | 16 | 0 |
| Target Price | ★ $43.94 | N/A |
| AVG Volume (30 Days) | ★ 4.8M | 839.8K |
| Earning Date | 02-03-2026 | 02-05-2026 |
| Dividend Yield | N/A | ★ 1.77% |
| EPS Growth | N/A | ★ 40.84 |
| EPS | 1.45 | ★ 6.55 |
| Revenue | $2,321,000,000.00 | ★ $5,373,647,000.00 |
| Revenue This Year | $6.23 | $1.71 |
| Revenue Next Year | $6.18 | $4.98 |
| P/E Ratio | $12.36 | ★ $11.40 |
| Revenue Growth | ★ 10.59 | N/A |
| 52 Week Low | $17.10 | $63.77 |
| 52 Week High | $79.57 | $100.00 |
| Indicator | BRBR | MMS |
|---|---|---|
| Relative Strength Index (RSI) | 25.61 | 28.61 |
| Support Level | $17.10 | $72.14 |
| Resistance Level | $25.75 | $79.93 |
| Average True Range (ATR) | 1.35 | 4.70 |
| MACD | -0.49 | -2.32 |
| Stochastic Oscillator | 7.30 | 8.47 |
BellRing Brands Inc is a United States-based company engaged in providing nutrition-related products. Its brands, Premier Protein, Dymatize, and PowerBar provides various products including ready-to-drink protein shakes, powders and nutrition bars. The company's products are distributed through a diverse network of channel including club, food, drug and mass, eCommerce, convenience and specialty.
Maximus Inc designs, develops, and delivers programs enabling people to access vital government services. It translates health and human services public policy into operating models that achieve outcomes for governments at scale. The company covers a broad array of services, including the operation of large health insurance eligibility and enrollment programs; clinical services, including assessments, appeals, and independent medical reviews; and technology services. The company operates through the following segments: U.S. Federal Services, U.S. Services, and Outside the U.S. A majority of its revenue is derived from the U.S. Federal Services segment, which engages with various U.S. federal government agencies to deliver clinical services, maintenance services, and technology solutions.